国：イギリス 取引所：IOB セクター：医療 産業：バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
バイオテクノロジー (25)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Novo Nordisk A/S 0QIU.IL | DKK 319.58 46.86 USD |
+3.28
|
DKK 1.34T 196.75B USD | DKK 899.93K 131.95K USD | DKK 314.50 46.11 USD | DKK 324.85 47.63 USD | DKK 1.34T 196.75B USD | 21.50 | DKK 14.86 2.18 USD | |
| UCB SA 0NZT.IL | €230.00 251.42 USD |
+1.21
|
€46.80B 51.16B USD | €72.68K 79.45K USD | €227.60 248.8 USD | €232.60 254.26 USD | €46.80B 51.16B USD | 135.29 | €1.70 1.86 USD | |
| argenx SE 0QW0.IL | €768.20 839.75 USD |
+0.87
|
€45.19B 49.4B USD | €7.93K 8.67K USD | €760.60 831.44 USD | €781.20 853.96 USD | €45.19B 49.4B USD | 0 | -€6.55 -7.1 USD | |
| Moderna, Inc. 0A45.IL | $26.20 — |
+4.28
|
$12.74B — | $39.28K — | $25.73 — | $26.81 — | $12.74B — | 9.77 | $2.68 — | |
| Bavarian Nordic A/S 0DPB.IL | DKK 230.25 33.76 USD |
0
|
DKK 21.61B 3.17B USD | DKK 7.91K 1.16K USD | DKK 188.25 27.6 USD | DKK 191.90 28.14 USD | DKK 21.61B 3.17B USD | 16.34 | DKK 14.09 2.07 USD | |
| Galapagos NV 0JXZ.IL | €28.32 30.96 USD |
+0.21
|
€1.87B 2.04B USD | €857.00 936.82 USD | €28.22 30.85 USD | €28.50 31.15 USD | €1.87B 2.04B USD | 0 | -€2.44 -2.6 USD | |
| Pharming Group N.V. 0QCO.IL | €1.47 1.6 USD |
+5.92
|
€1.15B 1.26B USD | €190.50K 208.24K USD | €1.41 1.54 USD | €1.48 1.62 USD | €1.15B 1.26B USD | 0 | -€0.02 -0.02 USD | |
| Idorsia Ltd 0RQE.IL | CHF 3.19 3.63 USD |
+2.49
|
CHF 810.10M 921.72M USD | CHF 173.14K 196.99K USD | CHF 3.17 3.61 USD | CHF 3.32 3.78 USD | CHF 810.10M 921.72M USD | 0 | -CHF 4.57 -5.1 USD | |
| DBV Technologies S.A. 0QAJ.IL | €2.45 2.68 USD |
+1.45
|
€277.89M 303.78M USD | €3.78K 4.13K USD | €2.43 2.66 USD | €2.58 2.82 USD | €277.89M 303.78M USD | 0 | -€0.93 -1.01 USD | |
| Cellectis S.A. 0WA2.IL | €3.33 3.64 USD |
+3.01
|
€240.62M 263.03M USD | €6.11K 6.68K USD | €3.28 3.58 USD | €3.53 3.85 USD | €240.62M 263.03M USD | 0 | -€1.42 -1.5 USD | |
| Genfit S.A. 0QT6.IL | €3.81 4.16 USD |
+4.56
|
€203.25M 222.18M USD | €10.75K 11.75K USD | €3.68 4.02 USD | €3.78 4.13 USD | €203.25M 222.18M USD | 0 | -€0.67 -0.7 USD | |
| Innate Pharma S.A. 0EVI.IL | €1.65 1.8 USD |
-3.91
|
€132.79M 145.16M USD | €9.11K 9.95K USD | €1.65 1.8 USD | €1.74 1.9 USD | €132.79M 145.16M USD | 0 | -€0.78 -0.8 USD | |
| Poxel S.A. 0RA2.IL | €0.27 0.29 USD |
+6.11
|
€9.50M 10.39M USD | €2.70K 2.95K USD | €0.25 0.27 USD | €0.26 0.28 USD | €9.50M 10.39M USD | 0 | -€1.09 -1.1 USD | |
| BioNTech SE 0A3M.IL | $112.50 — |
+2.74
|
$30.94B — | $198.60K — | $107.65 — | $113.50 — | $30.94B — | 6.25 | $18.00 — | |
| Genmab A/S 0MGB.IL | DKK 1,955.50 286.72 USD |
+2.92
|
DKK 156.60B 22.96B USD | DKK 20.57K 3.02K USD | DKK 1,953.00 286.35 USD | DKK 1,973.50 289.36 USD | DKK 156.60B 22.96B USD | 27.63 | DKK 70.77 10.38 USD | |
| ALK-Abelló A/S 0OIR.IL | DKK 149.45 21.91 USD |
0
|
DKK 30.00B 4.4B USD | DKK 4.75K 696.16 USD | DKK 204.40 29.97 USD | DKK 207.90 30.48 USD | DKK 30.00B 4.4B USD | 92.82 | DKK 1.61 0.24 USD | |
| Zealand Pharma A/S 0NZU.IL | DKK 501.35 73.51 USD |
+5.45
|
DKK 29.89B 4.38B USD | DKK 59.66K 8.75K USD | DKK 474.50 69.57 USD | DKK 503.20 73.78 USD | DKK 29.89B 4.38B USD | 0 | -DKK 15.13 -2.2 USD | |
| BioArctic AB (publ) 0RV2.IL | SEK 271.30 26.48 USD |
+3.35
|
SEK 27.14B 2.65B USD | SEK 91.89K 8.97K USD | SEK 265.00 25.87 USD | SEK 271.80 26.53 USD | SEK 27.14B 2.65B USD | 88.37 | SEK 3.07 0.3 USD | |
| Pharma Mar, S.A. 0RC6.IL | €74.60 81.55 USD |
+4.08
|
€1.35B 1.47B USD | €1.14K 1.25K USD | €72.10 78.82 USD | €75.20 82.2 USD | €1.35B 1.47B USD | 67.20 | €1.11 1.21 USD | |
| CureVac N.V. 0A9E.IL | $5.36 — |
+0.33
|
$1.34B — | $677.00 — | $5.25 — | $5.39 — | $1.34B — | 0 | -$1.50 — | |
| BioInvent International AB (publ) 0H22.IL | SEK 30.88 3.01 USD |
+0.65
|
SEK 2.17B 212.05M USD | SEK 494.06K 48.23K USD | SEK 31.48 3.07 USD | SEK 31.48 3.07 USD | SEK 2.17B 212.05M USD | 0 | -SEK 5.01 -0.4 USD | |
| Hansa Biopharma AB (publ) 0RC7.IL | SEK 27.11 2.65 USD |
+1.92
|
SEK 1.78B 174.1M USD | SEK 2.40K 234.37 USD | SEK 26.46 2.58 USD | SEK 27.28 2.66 USD | SEK 1.78B 174.1M USD | 0 | -SEK 16.03 -1.5 USD | |
| Thor Medical ASA 0R6Y.IL | NOK 3.65 0.35 USD |
+1.32
|
NOK 1.05B 100.45M USD | NOK 5.89K 564.54 USD | NOK 3.69 0.35 USD | NOK 3.70 0.35 USD | NOK 1.05B 100.45M USD | 0 | -NOK 1.17 -0.1 USD | |
| Oncopeptides AB (publ) 0RN4.IL | SEK 5.09 0.5 USD |
+3.35
|
SEK 522.02M 50.96M USD | SEK 134.00 13.08 USD | SEK 5.15 0.5 USD | SEK 5.15 0.5 USD | SEK 522.02M 50.96M USD | 0 | -SEK 3.39 -0.3 USD | |
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
||||||||||
- {{ link.label }} {{link}}